Assignee
NATCO PHARMA LTD
IN·33 granted patents·18 pending applications·50 citations·filing 1999–2023
Top patents by PatentIndex Score
51 records- 0188US9440959B2Process for the preparation of nilotinibNATCO PHARMA LTD·Filed 2015·Granted Sep 13, 2016·6 cites·4 claims
- 0285US7960545B2Process for the prepartion of erlotinibNATCO PHARMA LTD·Filed 2006·Granted Jun 14, 2011·10 cites·31 claims
- 0381US11498902B2Process for the preparation of Cabozantinib and its pharmaceutically acceptable salts thereofNATCO PHARMA LTD·Filed 2019·Granted Nov 15, 2022·6 cites·8 claims
- 0480US7910598B2Phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinaseNATCO PHARMA LTD·Filed 2007·Granted Mar 22, 2011·5 cites·40 claims
- 0573US9108945B2Anhydrous lenalidomide form-INATCO PHARMA LTD·Filed 2014·Granted Aug 18, 2015·2 cites·6 claims
- 0671US7939541B2Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamideNATCO PHARMA LTD·Filed 2008·Granted May 10, 2011·1 cites·9 claims
- 0770US9765072B21H-1,8-naphthyridin-2ones as anti proliferative compoundsNATCO PHARMA LTD·Filed 2014·Granted Sep 19, 2017·1 cites·7 claims
- 0870US2019201408A16,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumorsNATCO PHARMA LTD·Filed 2019·Application pending·0 cites
- 0968US10040778B2Anhydrous lenalidomide form-INATCO PHARMA LTD·Filed 2015·Granted Aug 7, 2018·1 cites·8 claims
- 1068US9481655B26,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumorsNATCO PHARMA LTD·Filed 2014·Granted Nov 1, 2016·0 cites·2 claims
- 1162US8349855B2Polymorphs of erlotinib hydrochloride and method of preparationNATCO PHARMA LTD·Filed 2007·Granted Jan 8, 2013·0 cites·4 claims
- 1260US8048883B2Polymorphic form of imatinib mesylate and a process for its preparationNATCO PHARMA LTD·Filed 2004·Granted Nov 1, 2011·3 cites·7 claims
- 1359US2024285642A1Egfr inhibitor for the treatment of head and neck cancerNATCO PHARMA LTD·Filed 2022·Application pending·0 cites
- 1458US6303787B1Intermediates and an improved process for the preparation of Omeprazole employing the said intermediatesNATCO PHARMA LTD·Filed 1999·Granted Oct 16, 2001·15 cites·10 claims
- 1558US2024199637A1Improved process for the preparation of 7-(morpholinyl)-2-(n-piperazinyl)methylthieno[2, 3-c]pyridine derivativesNATCO PHARMA LTD·Filed 2022·Application pending·0 cites
- 1655US12522611B2Process for the preparation of high pure Eribulin and its Mesylate saltNATCO PHARMA LTD·Filed 2019·Granted Jan 13, 2026·0 cites·11 claims
- 1755US2017079983A16,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumorsNATCO PHARMA LTD·Filed 2016·Application pending·0 cites
- 1854US2024352039A1Novel crystalline polymorph of lurbinectedin and improved process for the preparation of lurbinectedinNATCO PHARMA LTD·Filed 2022·Application pending·0 cites
- 1953US11452722B2Stable pharmaceutical compositions comprising lenalidomideNATCO PHARMA LTD·Filed 2019·Granted Sep 27, 2022·0 cites·3 claims
- 2053US8748602B2Polymorphs of erlotinib hydrochloride and method of preparationNATCO PHARMA LTD·Filed 2012·Granted Jun 10, 2014·0 cites·3 claims
- 2153US2026098048A1Improved process for the preparation of risdiplam and its intermediatesNATCO PHARMA LTD·Filed 2023·Application pending·0 cites
- 2253US2024376102A1An improved process for the preparation of ruxolitinib phosphateNATCO PHARMA LTD·Filed 2022·Application pending·0 cites
- 2353US2025026732A1An improved process for the preparation of crystalline form-a of cyantraniliproleNATCO PHARMA LTD·Filed 2022·Application pending·0 cites
- 2451US11576917B2Pharmaceutical compositions comprising IbrutinibNATCO PHARMA LTD·Filed 2019·Granted Feb 14, 2023·0 cites·7 claims
- 2551US2025221937A1Stable pharmaceutical compositions comprising erdafitinibNATCO PHARMA LTD·Filed 2023·Application pending·0 cites
- 2651US2007196463A1Enteric Soft Gelatin Capsule Containing Esomerpazole And Method Of PreparationNATCO PHARMA LTD·Filed 2004·Application pending·0 cites
- 2749US2005084530A1Rapid acting freeze dried oral pharmaceutical composition for treating migraineNATCO PHARMA LTD·Filed 2004·Application pending·0 cites
- 2848US11465988B2Process for the preparation of Tipiracil hydrochloride and intermediates thereofNATCO PHARMA LTD·Filed 2019·Granted Oct 11, 2022·0 cites·8 claims
- 2948US10047088B21H-1,8-naphthyridin-2-ones as anti proliferative compoundsNATCO PHARMA LTD·Filed 2017·Granted Aug 14, 2018·0 cites·5 claims
- 3048US2005095285A1Pharmaceutical composition and a process for its preparationNATCO PHARMA LTD·Filed 2004·Application pending·0 cites
- 3148US2024294549A1An improved process for the preparation of trabectedinNATCO PHARMA LTD·Filed 2022·Application pending·0 cites
- 3247US2023310327A1Pharmaceutical compositions comprising ribociclibNATCO PHARMA LTD·Filed 2021·Application pending·0 cites
- 3346US11008296B2Intermediates for the preparation of eribulin thereofNATCO PHARMA LTD·Filed 2018·Granted May 18, 2021·0 cites·10 claims
- 3446US2022259204A1A process for the preparation of venetoclax and its polymorphs thereofNATCO PHARMA LTD·Filed 2020·Application pending·0 cites
- 3545US11730753B2Stable pharmaceutical compositions comprising trifluridine and tipiracil hydrochlorideNATCO PHARMA LTD·Filed 2019·Granted Aug 22, 2023·0 cites·5 claims
- 3645US10870650B2Process for the preparation of amorphous idelalisibNATCO PHARMA LTD·Filed 2018·Granted Dec 22, 2020·0 cites·17 claims
- 3745US2024315978A1Pharmaceutical compositions comprising acalabrutinibNATCO PHARMA LTD·Filed 2022·Application pending·0 cites
- 3843US10383872B2Pharmaceutical compositions comprising phenylaminopyrimidine derivativeNATCO PHARMA LTD·Filed 2016·Granted Aug 20, 2019·0 cites·19 claims
- 3943US2011190328A1Acid addition salts of (3,5-bis trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamideNATCO PHARMA LTD·Filed 2011·Application pending·0 cites
- 4042US11111228B2Process for the preparation of pomalidomide and its purificationNATCO PHARMA LTD·Filed 2016·Granted Sep 7, 2021·0 cites·4 claims
- 4142US10966971B2Pharmaceutical compositions of pomalidomideNATCO PHARMA LTD·Filed 2017·Granted Apr 6, 2021·0 cites·3 claims
- 4241US12534467B2Process for the preparation of AcalabrutinibNATCO PHARMA LTD·Filed 2020·Granted Jan 27, 2026·0 cites·6 claims
- 4338US10800771B2Process for the preparation of dasatinib polymorphNATCO PHARMA LTD·Filed 2017·Granted Oct 13, 2020·0 cites·4 claims
- 4437US11845811B2Process for the preparation of Sugammadex sodium and its novel polymorphic formNATCO PHARMA LTD·Filed 2019·Granted Dec 19, 2023·0 cites·13 claims
- 4537US10626117B2Process for the preparation of IbrutinibNATCO PHARMA LTD·Filed 2017·Granted Apr 21, 2020·0 cites·13 claims
- 4637US10604505B2Modified process for the preparation of Ceritinib and amorphous form of CeritinibNATCO PHARMA LTD·Filed 2017·Granted Mar 31, 2020·0 cites·7 claims
- 4736US10106554B27-(morpholinyl)-2-(N-piperazinyl) methyl thieno [2, 3-C] pyridine derivatives as anticancer drugsNATCO PHARMA LTD·Filed 2014·Granted Oct 23, 2018·0 cites·7 claims
- 4835US9227948B2Process for the preparation of 2-substituted-2-(6-(substituted)-7-methylbenzo[D][1,3]dioxol-4-yl)acetic acid derivativesNATCO PHARMA LTD·Filed 2013·Granted Jan 5, 2016·0 cites·27 claims
- 4934US11091470B2Process for the preparation of N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin-4-amine dihydrochlorideNATCO PHARMA LTD·Filed 2017·Granted Aug 17, 2021·0 cites·9 claims
- 5032US11414421B2Process for the preparation of ribociclib succinate and its novel crystalline forms thereofNATCO PHARMA LTD·Filed 2019·Granted Aug 16, 2022·0 cites·8 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when NATCO PHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →